Loading…

Synthesis and evaluation of acylguanidine FXa inhibitors

A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compoun...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2008-08, Vol.18 (16), p.4696-4699
Main Authors: O’Connor, Stephen P., Atwal, Karnail, Li, Chi, Liu, Eddie C.-K., Seiler, Steven M., Shi, Mengxiao, Shi, Yan, Stein, Philip D., Wang, Ying
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03
cites cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03
container_end_page 4699
container_issue 16
container_start_page 4696
container_title Bioorganic & medicinal chemistry
container_volume 18
creator O’Connor, Stephen P.
Atwal, Karnail
Li, Chi
Liu, Eddie C.-K.
Seiler, Steven M.
Shi, Mengxiao
Shi, Yan
Stein, Philip D.
Wang, Ying
description A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is 1 with a FXa IC 50 of 6 nM.
doi_str_mv 10.1016/j.bmcl.2008.07.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19331450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X08007713</els_id><sourcerecordid>19331450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</originalsourceid><addsrcrecordid>eNp9kE9LxDAQR4Mouq5-AQ_Si95aJ202TcGLLP6DBQ8qeAvTZKpZuqkmrbDf3i676M3TXN77MTzGzjhkHLi8Wmb1yrRZDqAyKDMAsccmXEiRFgJm-2wClYRUVeLtiB3HuATgAoQ4ZEdcSSHKPJ8w9bz2_QdFFxP0NqFvbAfsXeeTrknQrNv3Ab2zzlNy94aJ8x-udn0X4gk7aLCNdLq7U_Z6d_syf0gXT_eP85tFaoTifcotklXGVMpWaPPKlkj1rKytNGCKUnGZF42yVsqmKHghydRYibIoCTlvGiim7HK7-xm6r4Fir1cuGmpb9NQNUfNq9MRsA-Zb0IQuxkCN_gxuhWGtOehNL73Um15600tDqcdeo3S-Wx_qFdk_ZRdoBC52AEaDbRPQGxd_uRwkKJlXI3e95Whs8e0o6GgceUPWBTK9tp37748fUeWJPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19331450</pqid></control><display><type>article</type><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><source>ScienceDirect Journals</source><creator>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</creator><creatorcontrib>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</creatorcontrib><description>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is 1 with a FXa IC 50 of 6 nM.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3405</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmcl.2008.07.004</identifier><identifier>PMID: 18644722</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Anticoagulants - chemical synthesis ; Anticoagulants - pharmacology ; Antithrombin III - chemical synthesis ; Antithrombin III - pharmacology ; Biological and medical sciences ; Blood Coagulation ; Blood. Blood coagulation. Reticuloendothelial system ; Carboxylic Acids - chemistry ; Chemistry, Pharmaceutical - methods ; Coagulation ; Drug Design ; Factor Xa ; Factor Xa - chemistry ; Guanidines - chemical synthesis ; Guanidines - pharmacology ; Guanine - chemistry ; Humans ; Imidazoles - chemistry ; Inhibitory Concentration 50 ; Medical sciences ; Models, Chemical ; Molecular Structure ; Pharmacology. Drug treatments ; Serine protease</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2008-08, Vol.18 (16), p.4696-4699</ispartof><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</citedby><cites>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20608629$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18644722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O’Connor, Stephen P.</creatorcontrib><creatorcontrib>Atwal, Karnail</creatorcontrib><creatorcontrib>Li, Chi</creatorcontrib><creatorcontrib>Liu, Eddie C.-K.</creatorcontrib><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Shi, Mengxiao</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Stein, Philip D.</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is 1 with a FXa IC 50 of 6 nM.</description><subject>Anticoagulants - chemical synthesis</subject><subject>Anticoagulants - pharmacology</subject><subject>Antithrombin III - chemical synthesis</subject><subject>Antithrombin III - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Carboxylic Acids - chemistry</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Coagulation</subject><subject>Drug Design</subject><subject>Factor Xa</subject><subject>Factor Xa - chemistry</subject><subject>Guanidines - chemical synthesis</subject><subject>Guanidines - pharmacology</subject><subject>Guanine - chemistry</subject><subject>Humans</subject><subject>Imidazoles - chemistry</subject><subject>Inhibitory Concentration 50</subject><subject>Medical sciences</subject><subject>Models, Chemical</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Serine protease</subject><issn>0960-894X</issn><issn>0968-0896</issn><issn>1464-3405</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LxDAQR4Mouq5-AQ_Si95aJ202TcGLLP6DBQ8qeAvTZKpZuqkmrbDf3i676M3TXN77MTzGzjhkHLi8Wmb1yrRZDqAyKDMAsccmXEiRFgJm-2wClYRUVeLtiB3HuATgAoQ4ZEdcSSHKPJ8w9bz2_QdFFxP0NqFvbAfsXeeTrknQrNv3Ab2zzlNy94aJ8x-udn0X4gk7aLCNdLq7U_Z6d_syf0gXT_eP85tFaoTifcotklXGVMpWaPPKlkj1rKytNGCKUnGZF42yVsqmKHghydRYibIoCTlvGiim7HK7-xm6r4Fir1cuGmpb9NQNUfNq9MRsA-Zb0IQuxkCN_gxuhWGtOehNL73Um15600tDqcdeo3S-Wx_qFdk_ZRdoBC52AEaDbRPQGxd_uRwkKJlXI3e95Whs8e0o6GgceUPWBTK9tp37748fUeWJPw</recordid><startdate>20080815</startdate><enddate>20080815</enddate><creator>O’Connor, Stephen P.</creator><creator>Atwal, Karnail</creator><creator>Li, Chi</creator><creator>Liu, Eddie C.-K.</creator><creator>Seiler, Steven M.</creator><creator>Shi, Mengxiao</creator><creator>Shi, Yan</creator><creator>Stein, Philip D.</creator><creator>Wang, Ying</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20080815</creationdate><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><author>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anticoagulants - chemical synthesis</topic><topic>Anticoagulants - pharmacology</topic><topic>Antithrombin III - chemical synthesis</topic><topic>Antithrombin III - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Carboxylic Acids - chemistry</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Coagulation</topic><topic>Drug Design</topic><topic>Factor Xa</topic><topic>Factor Xa - chemistry</topic><topic>Guanidines - chemical synthesis</topic><topic>Guanidines - pharmacology</topic><topic>Guanine - chemistry</topic><topic>Humans</topic><topic>Imidazoles - chemistry</topic><topic>Inhibitory Concentration 50</topic><topic>Medical sciences</topic><topic>Models, Chemical</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Serine protease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O’Connor, Stephen P.</creatorcontrib><creatorcontrib>Atwal, Karnail</creatorcontrib><creatorcontrib>Li, Chi</creatorcontrib><creatorcontrib>Liu, Eddie C.-K.</creatorcontrib><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Shi, Mengxiao</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Stein, Philip D.</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O’Connor, Stephen P.</au><au>Atwal, Karnail</au><au>Li, Chi</au><au>Liu, Eddie C.-K.</au><au>Seiler, Steven M.</au><au>Shi, Mengxiao</au><au>Shi, Yan</au><au>Stein, Philip D.</au><au>Wang, Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of acylguanidine FXa inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2008-08-15</date><risdate>2008</risdate><volume>18</volume><issue>16</issue><spage>4696</spage><epage>4699</epage><pages>4696-4699</pages><issn>0960-894X</issn><issn>0968-0896</issn><eissn>1464-3405</eissn><eissn>1464-3391</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is 1 with a FXa IC 50 of 6 nM.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18644722</pmid><doi>10.1016/j.bmcl.2008.07.004</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry, 2008-08, Vol.18 (16), p.4696-4699
issn 0960-894X
0968-0896
1464-3405
1464-3391
language eng
recordid cdi_proquest_miscellaneous_19331450
source ScienceDirect Journals
subjects Anticoagulants - chemical synthesis
Anticoagulants - pharmacology
Antithrombin III - chemical synthesis
Antithrombin III - pharmacology
Biological and medical sciences
Blood Coagulation
Blood. Blood coagulation. Reticuloendothelial system
Carboxylic Acids - chemistry
Chemistry, Pharmaceutical - methods
Coagulation
Drug Design
Factor Xa
Factor Xa - chemistry
Guanidines - chemical synthesis
Guanidines - pharmacology
Guanine - chemistry
Humans
Imidazoles - chemistry
Inhibitory Concentration 50
Medical sciences
Models, Chemical
Molecular Structure
Pharmacology. Drug treatments
Serine protease
title Synthesis and evaluation of acylguanidine FXa inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T04%3A34%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20acylguanidine%20FXa%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=O%E2%80%99Connor,%20Stephen%20P.&rft.date=2008-08-15&rft.volume=18&rft.issue=16&rft.spage=4696&rft.epage=4699&rft.pages=4696-4699&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2008.07.004&rft_dat=%3Cproquest_cross%3E19331450%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19331450&rft_id=info:pmid/18644722&rfr_iscdi=true